{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T06:03:35Z","timestamp":1779948215456,"version":"3.53.1"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001661","name":"Ruprecht-Karls-Universit\u00e4t Heidelberg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001661","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>AXIN1 is a central regulatory hub of many oncogenic pathways in colorectal cancer (CRC). As the main scaffold protein and least abundant component of the beta-catenin destruction complex, changes in AXIN1 levels tightly control Wnt signaling activity. How other cancer pathways beyond Wnt signaling regulate cellular AXIN1 levels is incompletely understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Colorectal cancer cell lines, murine and patient-derived intestinal and cancer organoids were used as model systems. Changes in AXIN1 levels upon drug perturbation were profiled by immunoblot, qPCR and RNA-seq.\u00a0Ubiquitin-affinity immunoprecipitation assays and mass spectrometry were used to determine mechanisms of AXIN1 loss. To characterize effects on protein synthesis, we performed polysome and ribosome profiling (Ribo-seq).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We show that targeting the Ras-MAPK pathway using clinically approved MEK1\/2 inhibitors induces AXIN1 loss across a panel of CRC cell lines and patient-derived organoids. In contrast to GSK3 inhibitors, MEK1\/2 inhibition neither affects protein stability nor post-translational modifications of AXIN1 and only caused a minor reduction of\n                      <jats:italic>AXIN1<\/jats:italic>\n                      transcript levels. Co-treatment with tankyrase inhibitors could partially prevent loss of AXIN1 upon MEK1\/2 inhibition. Using isogenic CRC cell lines and murine intestinal organoids, we show that APC truncations strongly reduce basal cellular AXIN1 levels, but do not alter dynamics of AXIN1 loss after MEK1\/2 inhibition. Polysome profiling and Ribo-seq revealed that MEK1\/2 inhibitors reduce global protein synthesis via an mTOR associated pathway. This translational repression is sufficient to cause significant AXIN1 loss, as treatment with mTOR or S6K inhibitors phenocopies the effect of MEK1\/2 inhibitors.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our study demonstrates that AXIN1 protein homeostasis is critically controlled by Ras-MAPK signaling at the level of protein synthesis, and that MEK1\/2 inhibitors cause AXIN1 loss by global translational repression.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12964-026-02963-4","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T09:02:42Z","timestamp":1779872562000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ras-MAPK inhibition induces AXIN1 loss in colorectal cancer by mTOR associated suppression of protein synthesis"],"prefix":"10.1186","volume":"24","author":[{"given":"Nachiyappan","family":"Venkatachalam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niyumi","family":"Muthukumarana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Ihnatko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen","family":"Krijgsveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Skabkina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Leipertz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Sui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panpan","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Descot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Schewe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Diamante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rene","family":"Jackstadt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Brochhausen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Betge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Boonekamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Boutros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Stoecklin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Ebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Schott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianzuo","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"issue":"3","key":"2963_CR1","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3322\/CAAC.21772","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2023. CA Cancer J Clin. 2023;73(3):233\u201354. https:\/\/doi.org\/10.3322\/CAAC.21772.\u00a0PubMed PMID: 36856579.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"2963_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep29765","volume":"6","author":"M Riihimaki","year":"2016","unstructured":"Riihimaki M, Hemminki A, Sundquist J, Hemminki K. Patterns of metastasis in colon and rectal cancer. Sci Rep. 2016;6(1):1\u20139. https:\/\/doi.org\/10.1038\/srep29765. PubMed PMID: 27416752.","journal-title":"Sci Rep"},{"issue":"1","key":"2963_CR3","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.annonc.2022.10.003","volume":"34","author":"A Cervantes","year":"2023","unstructured":"Cervantes A, Adam R, Rosell\u00f3 S, Arnold D, Normanno N, Ta\u00efeb J, et al. Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up \u2606. Ann Oncol. 2023;34(1):10\u201332. https:\/\/doi.org\/10.1016\/j.annonc.2022.10.003 . PubMed PMID: 36307056.","journal-title":"Ann Oncol"},{"issue":"34","key":"2963_CR4","doi-asserted-by":"publisher","first-page":"4032","DOI":"10.1200\/JCO.2015.63.2497","volume":"33","author":"S Kopetz","year":"2015","unstructured":"Kopetz S, Desai J, Chan E, Hecht JR, O\u2019Dwyer PJ, Maru D, et al. Phase II pilot study of vemurafenib in patients with metastatic BRAF-mutated colorectal cancer. J Clin Oncol. 2015;33(34):4032\u20138. .2497. PubMed PMID: 26460303.","journal-title":"J Clin Oncol"},{"issue":"8","key":"2963_CR5","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/S1470-2045(12)70270-X","volume":"13","author":"JR Infante","year":"2012","unstructured":"Infante JR, Fecher LA, Falchook GS, Nallapareddy S, Gordon MS, Becerra C, et al. Safety, pharmacokinetic, pharmacodynamic, and efficacy data for the oral MEK inhibitor trametinib: a phase 1 dose-escalation trial. Lancet Oncol. 2012;13(8):773\u201381. (12)70270-X. PubMed PMID: 22805291.","journal-title":"Lancet Oncol"},{"issue":"11","key":"2963_CR6","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/S41571-018-0105-0","volume":"15","author":"MB Ryan","year":"2018","unstructured":"Ryan MB, Corcoran RB. Therapeutic strategies to target RAS-mutant cancers. Nat Rev Clin Oncol. 2018;15(11):709\u201320. https:\/\/doi.org\/10.1038\/S41571-018-0105-0 . PubMed PMID: 30275515.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"2963_CR7","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1038\/s41467-019-09898-0","volume":"10","author":"T Zhan","year":"2019","unstructured":"Zhan T, Ambrosi G, Wandmacher AM, Rauscher B, Betge J, Rindtorff N, et al. MEK inhibitors activate Wnt signalling and induce stem cell plasticity in colorectal cancer. Nat Commun. 2019;10(1):2197. https:\/\/doi.org\/10.1038\/s41467-019-09898-0 . PubMed PMID: 31097693.","journal-title":"Nat Commun"},{"key":"2963_CR8","doi-asserted-by":"publisher","unstructured":"White M, Mills ML, Millett LM, Gilroy K, Hong Y, Zeiger LB et al. MAPK-driven epithelial cell plasticity drives colorectal cancer therapeutic resistance. Nature. 2025. https:\/\/doi.org\/10.1038\/S41586-025-09916-W. PubMed PMID: 41286180.","DOI":"10.1038\/S41586-025-09916-W"},{"key":"2963_CR9","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-25-0679","author":"A Centonze","year":"2025","unstructured":"Centonze A, Roura AJ, Novillo-Font M, Giordano C, Hernando-Momblona X, Llanses M, et al. A plastic EMP1+ to LGR5+ cell state conversion as a bypass to KRAS-G12D pharmacological inhibition in metastatic colorectal cancer. Cancer Discov. 2025. https:\/\/doi.org\/10.1158\/2159-8290.CD-25-0679 . PubMed PMID: 41128661.","journal-title":"Cancer Discov"},{"key":"2963_CR10","doi-asserted-by":"publisher","DOI":"10.1101\/2025.01.22.634215","author":"OE Villarreal","year":"2025","unstructured":"Villarreal OE, Xu Y, Tran H, Machado A, Prescod D, Anderson A, et al. Adaptive Plasticity Tumor Cells Modulate MAPK-Targeting Therapy Response in Colorectal Cancer. bioRxiv. 2025https:\/\/doi.org\/10.1101\/2025.01.22.634215.","journal-title":"bioRxiv"},{"issue":"11","key":"2963_CR11","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1038\/onc.2016.304","volume":"36","author":"T Zhan","year":"2017","unstructured":"Zhan T, Rindtorff N, Boutros M. Wnt signaling in cancer. Oncogene. 2017;36(11):1461\u201373. https:\/\/doi.org\/10.1038\/onc.2016.304. PubMed PMID: 27617575.","journal-title":"Oncogene"},{"issue":"6","key":"2963_CR12","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.cell.2012.05.002","volume":"149","author":"VSW Li","year":"2012","unstructured":"Li VSW, Ng SS, Boersema PJ, Low TY, Karthaus WR, Gerlach JP, et al. Wnt Signaling through Inhibition of \u03b2-Catenin Degradation in an Intact Axin1 Complex. Cell. 2012;149(6):1245\u201356. https:\/\/doi.org\/10.1016\/j.cell.2012.05.002 . PubMed PMID: 22682247.","journal-title":"Cell"},{"key":"2963_CR13","doi-asserted-by":"publisher","unstructured":"Qiu L, Sun Y, Ning H, Chen G, Zhao W, Gao Y. The scaffold protein AXIN1: gene ontology, signal network, and physiological function. Cell Commun Signal. 2024;22(1). https:\/\/doi.org\/10.1186\/S12964-024-01482-4 . PubMed PMID: 38291457.","DOI":"10.1186\/S12964-024-01482-4"},{"issue":"5","key":"2963_CR14","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/emboj.2008.279","volume":"28","author":"HK Arnold","year":"2009","unstructured":"Arnold HK, Zhang X, Daniel CJ, Tibbitts D, Escamilla-Powers J, Farrell A, et al. The Axin1 scaffold protein promotes formation of a degradation complex for c-Myc. EMBO J. 2009;28(5):500\u201312. https:\/\/doi.org\/10.1038\/emboj.2008.279.","journal-title":"EMBO J"},{"issue":"8","key":"2963_CR15","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1038\/sj.emboj.7601057","volume":"25","author":"W Liu","year":"2006","unstructured":"Liu W, Rui H, Wang J, Lin S, He Y, Chen M, et al. Axin is a scaffold protein in TGF-\u03b2 signaling that promotes degradation of Smad7 by Arkadia. EMBO J. 2006;25(8):1646\u201358. https:\/\/doi.org\/10.1038\/sj.emboj.7601057 . PubMed PMID: 16601693.","journal-title":"EMBO J"},{"issue":"12","key":"2963_CR16","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1007\/S00439-022-02463-8","volume":"141","author":"S Suthon","year":"2022","unstructured":"Suthon S, Perkins RS, Lin J, Crockarell JR, Miranda-Carboni GA, Krum SA. GATA4 and estrogen receptor alpha bind at SNPs rs9921222 and rs10794639 to regulate AXIN1 expression in osteoblasts. Hum Genet. 2022;141(12):1849\u201361. https:\/\/doi.org\/10.1007\/S00439-022-02463-8 . PubMed PMID: 35678873.","journal-title":"Hum Genet"},{"key":"2963_CR17","doi-asserted-by":"publisher","unstructured":"Chimge NO, Little GH, Baniwal SK, Adisetiyo H, Xie Y, Zhang T, et al. RUNX1 prevents oestrogen-mediated AXIN1 suppression and \u03b2-catenin activation in ER-positive breast cancer. Nat Commun. 2016;7. https:\/\/doi.org\/10.1038\/NCOMMS10751 . PubMed PMID: 26916619.","DOI":"10.1038\/NCOMMS10751"},{"issue":"17","key":"2963_CR18","doi-asserted-by":"publisher","first-page":"3519","DOI":"10.1158\/0008-5472.CAN-20-0216","volume":"80","author":"DN Jackson","year":"2020","unstructured":"Jackson DN, Alula KM, Delgado-Deida Y, Tabti R, Turner K, Wang X, et al. The synthetic small molecule FL3 combats intestinal tumorigenesis via axin1-mediated inhibition of Wnt\/b-catenin signaling. Cancer Res. 2020;80(17):3519\u201329. https:\/\/doi.org\/10.1158\/0008-5472.CAN-20-0216 . PubMed PMID: 32665357.","journal-title":"Cancer Res"},{"key":"2963_CR19","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jnutbio.2016.07","volume":"37","author":"M Zhang","year":"2016","unstructured":"Zhang M, Liao Y, L\u00f6nnerdal B. EGR-1 is an active transcription factor in TGF-\u03b22-mediated small intestinal cell differentiation. J Nutr Biochem. 2016;37:101\u20138. https:\/\/doi.org\/10.1016\/j.jnutbio.2016.07. .020. PubMed PMID: 27697743.","journal-title":"J Nutr Biochem"},{"issue":"5","key":"2963_CR20","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/ncb2222","volume":"13","author":"Y Zhang","year":"2011","unstructured":"Zhang Y, Liu S, Mickanin C, Feng Y, Charlat O, Michaud GA, et al. RNF146 is a poly(ADP-ribose)-directed E3 ligase that regulates axin degradation and Wnt signalling. Nat Cell Biol. 2011;13(5):623\u20139. https:\/\/doi.org\/10.1038\/ncb2222 . PubMed PMID: 21478859.","journal-title":"Nat Cell Biol"},{"issue":"7264","key":"2963_CR21","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/nature08356","volume":"461","author":"SMA Huang","year":"2009","unstructured":"Huang SMA, Mishina YM, Liu S, Cheung A, Stegmeier F, Michaud GA, et al. Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling. Nature. 2009;461(7264):614\u201320. https:\/\/doi.org\/10.1038\/nature08356 . PubMed PMID: 19759537.","journal-title":"Nature"},{"issue":"47","key":"2963_CR22","doi-asserted-by":"publisher","first-page":"36420","DOI":"10.1074\/jbc.M110.137471","volume":"285","author":"S Kim","year":"2010","unstructured":"Kim S, Jho EH. The protein stability of Axin, a negative regulator of Wnt signaling, is regulated by Smad ubiquitination regulatory factor 2 (Smurf2). J Biol Chem. 2010;285(47):36420\u20136. https:\/\/doi.org\/10.1074\/jbc.M110.137471 . PubMed PMID: 20858899.","journal-title":"J Biol Chem"},{"issue":"9","key":"2963_CR23","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1101\/gad.300053.117","volume":"31","author":"L Ji","year":"2017","unstructured":"Ji L, Jiang B, Jiang X, Charlat O, Chen A, Mickanin C, et al. The SIAH E3 ubiquitin ligases promote Wnt\/\u03b2-catenin signaling through mediating Wnt-induced Axin degradation. Genes Dev. 2017;31(9):904\u201315. https:\/\/doi.org\/10.1101\/gad.300053.117 . PubMed PMID: 28546513.","journal-title":"Genes Dev"},{"issue":"18","key":"2963_CR24","doi-asserted-by":"publisher","first-page":"3108","DOI":"10.1242\/jcs.206623","volume":"130","author":"YF Yang","year":"2017","unstructured":"Yang YF, Zhang MF, Tian QH, Zhang CZ. TRIM65 triggers \u03b2-catenin signaling via ubiquitylation of Axin1 to promote hepatocellular carcinoma. J Cell Sci. 2017;130(18):3108\u201315. https:\/\/doi.org\/10.1242\/jcs.206623 . PubMed PMID: 28754688.","journal-title":"J Cell Sci"},{"issue":"10","key":"2963_CR25","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1128\/MCB.01094-10","volume":"31","author":"TTH Lui","year":"2011","unstructured":"Lui TTH, Lacroix C, Ahmed SM, Goldenberg SJ, Leach CA, Daulat AM, et al. The Ubiquitin-Specific Protease USP34 Regulates Axin Stability and Wnt\/\u03b2-Catenin Signaling. Mol Cell Biol. 2011;31(10):2053\u201365. https:\/\/doi.org\/10.1128\/MCB.01094-10 . PubMed PMID: 21383061.","journal-title":"Mol Cell Biol"},{"key":"2963_CR26","doi-asserted-by":"publisher","unstructured":"Ji L, Lu B, Zamponi R, Charlat O, Aversa R, Yang Z, et al. USP7 inhibits Wnt\/\u03b2-catenin signaling through promoting stabilization of Axin. Nat Commun. 2019;10(1). https:\/\/doi.org\/10.1038\/s41467-019-12143-3 . PubMed PMID: 31519875.","DOI":"10.1038\/s41467-019-12143-3"},{"issue":"3","key":"2963_CR27","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.ccell.2019.08.003","volume":"36","author":"R Jackstadt","year":"2019","unstructured":"Jackstadt R, van Hooff SR, Leach JD, Cortes-Lavaud X, Lohuis JO, Ridgway RA, et al. Epithelial NOTCH Signaling Rewires the Tumor Microenvironment of Colorectal Cancer to Drive Poor-Prognosis Subtypes and Metastasis. Cancer Cell. 2019;36(3):319\u2013e3367. .003. PubMed PMID: 31526760.","journal-title":"Cancer Cell"},{"key":"2963_CR28","doi-asserted-by":"publisher","unstructured":"Hughes CS, Moggridge S, M\u00fcller T, Sorensen PH, Morin GB, Krijgsveld J. Single-pot, solid-phase-enhanced sample preparation for proteomics experiments. Nat Protoc. 2019;14(1):68\u201385. https:\/\/doi.org\/10.1038\/S41596-018-0082-X. PubMed PMID: 30464214.","DOI":"10.1038\/S41596-018-0082-X"},{"issue":"8","key":"2963_CR29","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1021\/pr060050o","volume":"5","author":"SJ Callister","year":"2006","unstructured":"Callister SJ, Dominguez MA, Nicora CD, Zeng X, Tavano CL, Kaplan S, et al. Application of the accurate mass and time tag approach to the proteome analysis of sub-cellular fractions obtained from Rhodobacter sphaeroides 2.4.1. aerobic and photosynthetic cell cultures. J Proteome Res. 2006;5(8):1940\u20137. 10.1021\/PR060050O. PubMed PMID: 16889416.","journal-title":"J Proteome Res"},{"key":"2963_CR30","doi-asserted-by":"publisher","unstructured":"Nie L, Wang C, Li N, Feng X, Lee N, Su D, et al. Proteome-wide Analysis Reveals Substrates of E3 Ligase RNF146 Targeted for Degradation. Mol Cell Proteomics. 2020;19(12). https:\/\/doi.org\/10.1074\/mcp.RA120.002290 . PubMed PMID: 32958691.","DOI":"10.1074\/mcp.RA120.002290"},{"issue":"1","key":"2963_CR31","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/S12859-026-06379-2","volume":"27","author":"C Schiller","year":"2026","unstructured":"Schiller C, Lemmer M, Reitter S, Lehmann JA, Fenzl K, Schott J. QuAPPro: an R shiny app for quantification and alignment of polysome profiles. BMC Bioinformatics. 2026;27(1):22. https:\/\/doi.org\/10.1186\/S12859-026-06379-2 . PubMed PMID: 41572167.","journal-title":"BMC Bioinformatics"},{"key":"2963_CR32","doi-asserted-by":"publisher","unstructured":"Langmead B, Trapnell C, Pop M, Salzberg SL. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 2009;10(3). https:\/\/doi.org\/10.1186\/GB-2009-10-3-R25 . PubMed PMID: 19261174.","DOI":"10.1186\/GB-2009-10-3-R25"},{"key":"2963_CR33","doi-asserted-by":"publisher","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12). https:\/\/doi.org\/10.1186\/S13059-014-0550-8 . PubMed PMID: 25516281.","DOI":"10.1186\/S13059-014-0550-8"},{"issue":"1","key":"2963_CR34","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/BIOINFORMATICS\/BTS635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: Ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29(1):15\u201321. https:\/\/doi.org\/10.1093\/BIOINFORMATICS\/BTS635 . PubMed PMID: 23104886.","journal-title":"Bioinformatics"},{"issue":"7","key":"2963_CR35","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/BIOINFORMATICS\/BTT656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao Y, Smyth GK, Shi W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30(7):923\u201330. https:\/\/doi.org\/10.1093\/BIOINFORMATICS\/BTT656 . PubMed PMID: 24227677.","journal-title":"Bioinformatics"},{"key":"2963_CR36","doi-asserted-by":"publisher","unstructured":"Bankhead P, Loughrey MB, Fern\u00e1ndez JA, Dombrowski Y, McArt DG, Dunne PD, et al. QuPath: Open source software for digital pathology image analysis. Sci Rep. 2017;7(1). https:\/\/doi.org\/10.1038\/S41598-017-17204-5 . PubMed PMID: 29203879.","DOI":"10.1038\/S41598-017-17204-5"},{"issue":"16","key":"2963_CR37","doi-asserted-by":"publisher","first-page":"10681","DOI":"10.1074\/jbc.274.16.10681","volume":"274","author":"H Yamamoto","year":"1999","unstructured":"Yamamoto H, Kishida S, Kishida M, Ikeda S, Takada S, Kikuchi A. Phosphorylation of axin, a Wnt signal negative regulator, by glycogen synthase kinase-3\u03b2 regulates its stability. J Biol Chem. 1999;274(16):10681\u20134. https:\/\/doi.org\/10.1074\/jbc.274.16.10681 . PubMed PMID: 10196136.","journal-title":"J Biol Chem"},{"key":"2963_CR38","doi-asserted-by":"crossref","unstructured":"Li J, Cai Z, Vaites LP, Shen N, Mitchell DC, Huttlin EL et al. Proteome-wide mapping of short-lived proteins in human cells. Mol Cell. 2021;81(22):4722\u20134735.e5. 10.1016\/j.molcel.2021.09.015. PubMed PMID: 34626566.","DOI":"10.1016\/j.molcel.2021.09.015"},{"issue":"6630","key":"2963_CR39","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/387296a0","volume":"387","author":"Y Haupt","year":"1997","unstructured":"Haupt Y, Maya R, Kazaz A, Oren M. Mdm2 promotes the rapid degradation of p53. Nature. 1997;387(6630):296\u20139. 10.1038\/387296A0. PubMed PMID: 9153395.","journal-title":"Nature"},{"key":"2963_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7554\/eLife.59879","volume":"9","author":"MV Gammons","year":"2020","unstructured":"Gammons MV, Renko M, Flack JE, Mieszczanek J, Bienz M. Feedback control of wnt signaling based on ultrastable histidine cluster co-aggregation between Naked\/NKD and axin. Elife. 2020;9:1\u201322. .59879. PubMed PMID: 33025907.","journal-title":"Elife"},{"key":"2963_CR41","doi-asserted-by":"publisher","unstructured":"Callow MG, Tran H, Phu L, Lau T, Lee J, Sandoval WN, et al. Ubiquitin ligase RNF146 regulates tankyrase and Axin to promote Wnt signaling. PLoS ONE. 2011;6(7). https:\/\/doi.org\/10.1371\/journal.pone.0022595 . PubMed PMID: 21799911.","DOI":"10.1371\/journal.pone.0022595"},{"key":"2963_CR42","doi-asserted-by":"publisher","unstructured":"Imkeller K, Ambrosi G, Klemm N, Claveras Cabezudo A, Henkel L, Huber W, et al. Metabolic balance in colorectal cancer is maintained by optimal Wnt signaling levels. Mol Syst Biol. 2022;18(8). https:\/\/doi.org\/10.15252\/MSB.202110874.\u00a0PubMed PMID: 35904277.","DOI":"10.15252\/MSB.202110874"},{"key":"2963_CR43","doi-asserted-by":"publisher","unstructured":"Vaquero-Siguero N, Schleussner N, Volk J, Mastel M, Meier J, Jackstadt R. Modeling Colorectal Cancer Progression Reveals Niche-Dependent Clonal Selection. Cancers (Basel). 2022;14(17). https:\/\/doi.org\/10.3390\/CANCERS14174260.","DOI":"10.3390\/CANCERS14174260"},{"issue":"8","key":"2963_CR44","doi-asserted-by":"publisher","first-page":"102284","DOI":"10.1016\/J.XCRM.2025.102284","volume":"6","author":"Q Xiao","year":"2025","unstructured":"Xiao Q, Riedesser JE, Mulholland T, Li Z, Buchloh J, Albrecht P, et al. Combined MEK and PARP inhibition enhances radiation response in rectal cancer. Cell Rep Med. 2025;6(8):102284. https:\/\/doi.org\/10.1016\/J.XCRM.2025.102284.","journal-title":"Cell Rep Med"},{"issue":"10","key":"2963_CR45","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/S41580-020-0255-7","volume":"21","author":"H Lavoie","year":"2020","unstructured":"Lavoie H, Gagnon J, Therrien M. ERK signalling: a master regulator of cell behaviour, life and fate. Nat Rev Mol Cell Biol. 2020;21(10):607\u201332. https:\/\/doi.org\/10.1038\/S41580-020-0255-7 . PubMed PMID: 32576977.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"13","key":"2963_CR46","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1038\/onc.2013.113","volume":"33","author":"S Shin","year":"2014","unstructured":"Shin S, Wolgamott L, Tcherkezian J, Vallabhapurapu S, Yu Y, Roux PP, et al. Glycogen synthase kinase-3\u03b2 positively regulates protein synthesis and cell proliferation through the regulation of translation initiation factor 4E-binding protein 1. Oncogene. 2014;33(13):1690\u20139. PubMed PMID: 23584478.","journal-title":"Oncogene"},{"key":"2963_CR47","doi-asserted-by":"publisher","unstructured":"Shin S, Wolgamott L, Yu Y, Blenis J, Yoon SO. Glycogen synthase kinase (GSK)-3 promotes p70 ribosomal protein S6 kinase (p70S6K) activity and cell proliferation. Proc Natl Acad Sci U S A. 2011;108(47). https:\/\/doi.org\/10.1073\/PNAS.1110195108 . PubMed PMID: 22065737.","DOI":"10.1073\/PNAS.1110195108"},{"issue":"26","key":"2963_CR48","doi-asserted-by":"publisher","first-page":"15996","DOI":"10.1074\/jbc.M114.621730","volume":"290","author":"BD Fonseca","year":"2015","unstructured":"Fonseca BD, Zakaria C, Jia JJ, Graber TE, Svitkin Y, Tahmasebi S, et al. La-related protein 1 (LARP1) represses terminal oligopyrimidine (TOP) mRNA translation downstream of mTOR complex 1 (mTORC1). J Biol Chem. 2015;290(26):15996\u20136020. https:\/\/doi.org\/10.1074\/jbc.M114.621730 . PubMed PMID: 25940091.","journal-title":"J Biol Chem"},{"issue":"7","key":"2963_CR49","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.bbagrm.2014.08.015","volume":"1849","author":"O Meyuhas","year":"2015","unstructured":"Meyuhas O, Kahan T. The race to decipher the top secrets of TOP mRNAs. Biochim Biophys Acta Gene Regul Mech. 2015;1849(7):801\u201311. 015. PubMed PMID: 25234618.","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"issue":"5","key":"2963_CR50","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.stem.2011.02.020","volume":"8","author":"A Merlos-Su\u00e1rez","year":"2011","unstructured":"Merlos-Su\u00e1rez A, Barriga FM, Jung P, Iglesias M, C\u00e9spedes MV, Rossell D, et al. The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse. Cell Stem Cell. 2011;8(5):511\u201324. https:\/\/doi.org\/10.1016\/j.stem.2011.02.020 . PubMed PMID: 21419747.","journal-title":"Cell Stem Cell"},{"issue":"46","key":"2963_CR51","doi-asserted-by":"publisher","first-page":"29001","DOI":"10.1073\/pnas.2009334117","volume":"117","author":"EJ Lee","year":"2020","unstructured":"Lee EJ, Seo E, Kim JW, Nam SA, Lee JY, Jun J, et al. TAZ\/Wnt-\u03b2-catenin\/c-MYC axis regulates cystogenesis in polycystic kidney disease. Proc Natl Acad Sci U S A. 2020;117(46):29001\u201312. 10.1073\/PNAS.2009334117. PubMed PMID: 33122431.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"2963_CR52","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.cmet.2013.09.005","volume":"18","author":"YL Zhang","year":"2013","unstructured":"Zhang YL, Guo H, Zhang CS, Lin SY, Yin Z, Peng Y, et al. AMP as a low-energy charge signal autonomously initiates assembly of axin-ampk-lkb1 complex for AMPK activation. Cell Metab. 2013;18(4):546\u201355. PubMed PMID: 24093678.","journal-title":"Cell Metab"},{"key":"2963_CR53","doi-asserted-by":"publisher","unstructured":"Xie R, Yi D, Zeng D, Jie Q, Kang Q, Zhang Z et al. Specific deletion of Axin1 leads to activation of \u03b2-catenin\/BMP signaling resulting in fibular hemimelia phenotype in mice. Elife. 2022;11. https:\/\/doi.org\/10.7554\/ELIFE.80013. PubMed PMID: 36541713.","DOI":"10.7554\/ELIFE.80013"},{"issue":"206","key":"2963_CR54","doi-asserted-by":"publisher","first-page":"ra3","DOI":"10.1126\/scisignal.2002274","volume":"5","author":"TL Biechele","year":"2012","unstructured":"Biechele TL, Kulikauskas RM, Toroni RA, Lucero OM, Swift RD, James RG, et al. Wnt\/\u03b2-catenin signaling and AXIN1 regulate apoptosis triggered by inhibition of the mutant kinase BRAFV600Ein human melanoma. Sci Signal. 2012;5(206):ra3\u20133. https:\/\/doi.org\/10.1126\/scisignal.2002274 . PubMed PMID: 22234612.","journal-title":"Sci Signal"},{"key":"2963_CR55","doi-asserted-by":"crossref","unstructured":"Conrad WH, Swift RD, Biechele TL, Kulikauskas RM, Moon RT, Chien AJ. Regulating the response to targeted MEK inhibition in melanoma: enhancing apoptosis in NRAS- and BRAF-mutant melanoma cells with Wnt\/\u03b2-catenin activation. Cell Cycle. 2012;11(20):3724\u201330. [cited 2016 Feb 5]. Available from: http:\/\/www.tandfonline.com\/doi\/abs\/10.4161\/cc.21645.","DOI":"10.4161\/cc.21645"},{"key":"2963_CR56","doi-asserted-by":"publisher","unstructured":"Chen G, Gao C, Gao X, Zhang DH, Kuan SF, Burns TF et al. Wnt\/\u03b2-catenin pathway activation mediates adaptive resistance to BRAF inhibition in colorectal cancer. Mol Cancer Ther. 2017;17(4):molcanther.0561.2017. https:\/\/doi.org\/10.1158\/1535-7163.MCT-17-0561. PubMed PMID: 29167314.","DOI":"10.1158\/1535-7163.MCT-17-0561"},{"issue":"3","key":"2963_CR57","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.cmet.2014.06.014","volume":"20","author":"CS Zhang","year":"2014","unstructured":"Zhang CS, Jiang B, Li M, Zhu M, Peng Y, Zhang YL, et al. The lysosomal v-ATPase-ragulator complex is a common activator for AMPK and mTORC1, acting as a switch between catabolism and anabolism. Cell Metab. 2014;20(3):526\u201340. 014. PubMed PMID: 25002183.","journal-title":"Cell Metab"},{"issue":"9","key":"2963_CR58","first-page":"2277","volume":"18","author":"M Yan","year":"2024","unstructured":"Yan M, Su Z, Pang X, Wang H, Dai H, Ning J, et al. The CK1\u03b5\/SIAH1 axis regulates AXIN1 stability in colorectal cancer cells. Mol Oncol. 2024;18(9):2277\u201397. PubMed PMID: 38419282.","journal-title":"Mol Oncol"},{"key":"2963_CR59","doi-asserted-by":"publisher","unstructured":"Roux PP, Topisirovic I. Signaling Pathways Involved in the Regulation of mRNA Translation. Mol Cell Biol. 2018;38(12). https:\/\/doi.org\/10.1128\/MCB.00070-18 . PubMed PMID: 29610153.","DOI":"10.1128\/MCB.00070-18"},{"key":"2963_CR60","doi-asserted-by":"publisher","unstructured":"Proud CG. Phosphorylation and signal transduction pathways in translational control. Cold Spring Harb Perspect Biol. 2019;11(7). https:\/\/doi.org\/10.1101\/CSHPERSPECT.A033050. PubMed PMID: 29959191.","DOI":"10.1101\/CSHPERSPECT.A033050"},{"issue":"7516","key":"2963_CR61","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nature13572","volume":"513","author":"L Boussemart","year":"2014","unstructured":"Boussemart L, Malka-Mahieu H, Girault I, Allard D, Hemmingsson O, Tomasic G, et al. eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies. Nature. 2014;513(7516):105\u20139. https:\/\/doi.org\/10.1038\/nature13572 . PubMed PMID: 25079330.","journal-title":"Nature"},{"key":"2963_CR62","doi-asserted-by":"publisher","unstructured":"Corcoran RB, Rothenberg SM, Hata AN, Faber AC, Piris A, Nazarian RM, et al. TORC1 suppression predicts responsiveness to RAF and MEK inhibition in BRAF-mutant melanoma. Sci Transl Med. 2013;5(196). https:\/\/doi.org\/10.1126\/SCITRANSLMED.3005753. PubMed PMID: 23903755.","DOI":"10.1126\/SCITRANSLMED.3005753"},{"issue":"3","key":"2963_CR63","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.jcmgh.2020.04","volume":"10","author":"A Prossomariti","year":"2020","unstructured":"Prossomariti A, Piazzi G, Alquati C, Ricciardiello L. Are Wnt\/\u03b2-Catenin and PI3K\/AKT\/mTORC1 Distinct Pathways in Colorectal Cancer? CMGH. 2020;10(3):491\u2013506. https:\/\/doi.org\/10.1016\/j.jcmgh.2020.04. .007. PubMed PMID: 32334125.","journal-title":"CMGH"},{"issue":"3","key":"2963_CR64","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.stem.2009.06.017","volume":"5","author":"RM Castilho","year":"2009","unstructured":"Castilho RM, Squarize CH, Chodosh LA, Williams BO, Gutkind JS. mTOR Mediates Wnt-Induced Epidermal Stem Cell Exhaustion and Aging. Cell Stem Cell. 2009;5(3):279\u201389. https:\/\/doi.org\/10.1016\/j.stem.2009.06.017 . PubMed PMID: 19733540.","journal-title":"Cell Stem Cell"},{"issue":"5","key":"2963_CR65","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.cell.2006.06.055","volume":"126","author":"K Inoki","year":"2006","unstructured":"Inoki K, Ouyang H, Zhu T, Lindvall C, Wang Y, Zhang X, et al. TSC2 Integrates Wnt and Energy Signals via a Coordinated Phosphorylation by AMPK and GSK3 to Regulate Cell Growth. Cell. 2006;126(5):955\u201368. https:\/\/doi.org\/10.1016\/j.cell.2006.06.055 . PubMed PMID: 16959574.","journal-title":"Cell"},{"issue":"38","key":"2963_CR66","doi-asserted-by":"publisher","first-page":"14723","DOI":"10.1074\/jbc.RA118.002800","volume":"293","author":"SJ Bautista","year":"2018","unstructured":"Bautista SJ, Boras I, Vissa A, Mecica N, Yip CM, Kim PK, et al. mTOR complex 1 controls the nuclear localization and function of glycogen synthase kinase 3\u03b2. J Biol Chem. 2018;293(38):14723\u201339. https:\/\/doi.org\/10.1074\/jbc.RA118.002800 . PubMed PMID: 30061153.","journal-title":"J Biol Chem"},{"issue":"44","key":"2963_CR67","doi-asserted-by":"publisher","first-page":"E10362","DOI":"10.1073\/pnas.1808575115","volume":"115","author":"H Zeng","year":"2018","unstructured":"Zeng H, Lu B, Zamponi R, Yang Z, Wetzel K, Loureiro J, et al. MTORC1 signaling suppresses Wnt\/\u03b2-catenin signaling through DVL-dependent regulation of Wnt receptor FZD level. Proc Natl Acad Sci U S A. 2018;115(44):E10362\u20139. 10.1073\/PNAS.1808575115. PubMed PMID: 30297426.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"2963_CR68","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1074\/jbc.275.4.2399","volume":"275","author":"ET Strovel","year":"2000","unstructured":"Strovel ET, Wu D, Sussman DJ. Protein phosphatase 2C\u03b1 dephosphorylates axin and activates LEF-1- dependent transcription. J Biol Chem. 2000;275(4):2399\u2013403. https:\/\/doi.org\/10.1074\/jbc.275.4.2399 . PubMed PMID: 10644691.","journal-title":"J Biol Chem"},{"issue":"14","key":"2963_CR69","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1101\/gad.13.14.1768","volume":"13","author":"K Willert","year":"1999","unstructured":"Willert K, Shibamoto S, Nusse R. Wnt-induced dephosphorylation of Axin releases \u03b2-catenin from the Axin complex. Genes Dev. 1999;13(14):1768\u201373. https:\/\/doi.org\/10.1101\/gad.13.14.1768 . PubMed PMID: 10421629.","journal-title":"Genes Dev"},{"key":"2963_CR70","doi-asserted-by":"publisher","unstructured":"Cantoria MJ, Alizadeh E, Ravi J, Varghese RP, Bunnag N, Pond KW, et al. Feedback in the \u03b2-catenin destruction complex imparts bistability and cellular memory. Proc Natl Acad Sci U S A. 2023;120(2). https:\/\/doi.org\/10.1073\/PNAS.2208787120. PubMed PMID: 36598937.","DOI":"10.1073\/PNAS.2208787120"},{"issue":"1","key":"2963_CR71","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1006\/bbrc.1999.1760","volume":"266","author":"EH Jho","year":"1999","unstructured":"Jho EH, Lomvardas S, Costantini F. A GSK3\u03b2 phosphorylation site in Axin modulates interaction with \u03b2-catenin and Tcf-mediated gene expression. Biochem Biophys Res Commun. 1999;266(1):28\u201335. https:\/\/doi.org\/10.1006\/bbrc.1999.1760 . PubMed PMID: 10581160.","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-026-02963-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-02963-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-02963-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T05:37:27Z","timestamp":1779946647000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12964-026-02963-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2963"],"URL":"https:\/\/doi.org\/10.1186\/s12964-026-02963-4","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,27]]},"assertion":[{"value":"16 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Experiments with patient-derived cancer organoids were approved by the Medical Ethics Committee II of the Medical Faculty Mannheim, Heidelberg University (Reference no. 2014\u2013633\u00a0N-MA and 2016\u2013607\u00a0N-MA). Written informed consent was obtained from patients before performing any experimental procedures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"324"}}